Corporate Profile
Sana Biotechnology, Inc. is focused on creating and delivering engineered cells as medicines for patients. We share a vision of repairing and controlling genes, replacing missing or damaged cells, and making our therapies broadly available to patients. We are working together to create an enduring company that changes how the world treats disease. Sana has operations in Seattle, Cambridge, and South San Francisco.
Data Provided by Refinitiv. Minimum 15 minutes delayed.
News Releases
Sep 09, 2022
Aug 04, 2022
Jun 17, 2022
Events
Sep 29, 2022 at 11:00 AM PDT
Sep 13, 2022 at 11:55 AM PDT
Jun 14, 2022 at 4:00 PM PDT
SEC Filings
| Filing date | Description | Form |
|---|---|---|
An amendment to a 3 filing. Non-EDGAR filing |
3/A | |
Initial filing by director officer or owner of more than ten percent. |
3 | |
Statement of changes in beneficial ownership of securities |
4 |